Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)

ClinicalTrials.gov ID: NCT01195636

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01195636. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 9:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, and Systemic Exposure of Topical XPF-002 in Subjects With Postherpetic Neuralgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to determine if XPF-002 is safe and effective for the treatment of pain in subjects with Postherpetic Neuralgia

Study identification

NCT ID
NCT01195636
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
Mar 2011 (Actual)
Last update posted
Nov 25, 2013

2010 – 2011

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Not listed Jonesboro Arkansas — —
Not listed Lomita California — —
Not listed Westlake Village California — —
Not listed Bradenton Florida — —
Not listed Naples Florida — —
Not listed New Port Richey Florida — —
Not listed Ocala Florida — —
Not listed Sunrise Florida — —
Not listed Tampa Florida — —
Not listed Atlanta Georgia — —
Not listed Decatur Georgia — —
Not listed Marietta Georgia — —
Not listed Lexington Kentucky — —
Not listed Bay City Michigan — —
Not listed St Louis Missouri — —
Not listed Las Vegas Nevada — —
Not listed Albuquerque New Mexico — —
Not listed Hartsdale New York — —
Not listed Oklahoma City Oklahoma — —
Not listed Philadelphia Pennsylvania — —
Not listed West Reading Pennsylvania — —
Not listed Austin Texas — —
Not listed Houston Texas — —
Not listed Sugar Land Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01195636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2013 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.